KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Short-term Investments (2016 - 2025)

Acadia Pharmaceuticals has reported Short-term Investments over the past 16 years, most recently at $642.0 million for Q4 2025.

  • Quarterly results put Short-term Investments at $642.0 million for Q4 2025, up 47.11% from a year ago — trailing twelve months through Dec 2025 was $642.0 million (up 47.11% YoY), and the annual figure for FY2025 was $642.0 million, up 47.11%.
  • Short-term Investments for Q4 2025 was $642.0 million at Acadia Pharmaceuticals, up from $589.0 million in the prior quarter.
  • Over the last five years, Short-term Investments for ACAD hit a ceiling of $642.0 million in Q4 2025 and a floor of $112.0 million in Q1 2023.
  • Median Short-term Investments over the past 5 years was $299.2 million (2022), compared with a mean of $351.0 million.
  • Biggest five-year swings in Short-term Investments: plummeted 53.55% in 2023 and later surged 137.35% in 2024.
  • Acadia Pharmaceuticals' Short-term Investments stood at $373.3 million in 2021, then dropped by 19.1% to $302.0 million in 2022, then fell by 17.14% to $250.2 million in 2023, then surged by 74.42% to $436.4 million in 2024, then skyrocketed by 47.11% to $642.0 million in 2025.
  • The last three reported values for Short-term Investments were $642.0 million (Q4 2025), $589.0 million (Q3 2025), and $508.4 million (Q2 2025) per Business Quant data.